GRIFOLS | GRF - Ebitda



GRIFOLS reported EUR347.24M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Alcon AG USD 250M 213M Jun/2025
Almirall EUR 76.3M 8.43M Mar/2025
Amadeus IT EUR 647.7M 19.4M Jun/2025
Amarin USD -16025000 714K Mar/2025
argenx SE 288.02M 84.53M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Cie Automotive EUR 345.96M 35.96M Dec/2024
Demant DKK 2.59B 473M Jun/2025
Ence Energia y Celulosa EUR 23.5M 28M Jun/2025
Essilor EUR 3.09B 356M Dec/2024
Ferrovial EUR 586M 17M Dec/2024
Fresenius EUR 828M 88M Jun/2025
Fresenius Medical Care EUR 871M 282M Jun/2025
Galapagos EUR -158708000 177.84M Mar/2025
Genmab DKK 376M 172M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 2.39B 458.01M Apr/2025
Merck EUR 1.46B 45M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Philips EUR 747M 174M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
Smith & Nephew USD 796M 48.8M Jun/2025
UCB EUR 1.37B 715M Dec/2024
Viscofan EUR 66.91M 1.73M Jun/2025